Cantitate/Preț
Produs

Pharmacogenetics of Breast Cancer: Towards the Individualization of Therapy: Translational Medicine

Editat de Brian Leyland-Jones
en Limba Engleză Paperback – 19 mai 2008
Pharmacogenetics is becoming increasingly relevant in the diagnosis, treatment, and recovery of cancer patients. A major problem facing oncologists is the outstanding varied efficacy of treatment. Promising advances in pharmacogenetics have allowed the development of effective agents which will enable personalized cancer chemotherapy to become routine for the clinical practice.
Written by experts in the field and combining information that is unable to be found in a single source volume, Pharmacogenetics of Breast Cancer:
  • combines a complete overview of pharmacogenetics and how it relates to breast oncology for diagnosis, treatment, and the recovery of patients using an individualized therapy model
  • is the first single source reference demonstrating the application of pharmacogenetics in the care of breast cancer patients
  • enables physicians a coherent interpretation of the emerging science of pharmacogenetics, aiding them to incorporate individual therapies in their own practice
  • gives practical guidance on various forms of specimen collection, tissue selection, and handling procedures
Citește tot Restrânge

Preț: 64405 lei

Preț vechi: 67794 lei
-5% Nou

Puncte Express: 966

Preț estimativ în valută:
12326 12841$ 10248£

Carte tipărită la comandă

Livrare economică 08-22 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781420086379
ISBN-10: 1420086375
Pagini: 350
Ilustrații: 50 b/w images, 13 tables and 14 halftones
Dimensiuni: 152 x 229 mm
Greutate: 0.48 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Translational Medicine

Locul publicării:Boca Raton, United States

Public țintă

Professional Reference

Cuprins

Pharmacogenomic approaches. Individualized kinetics and dosing. Clasical IHC and FISH state of the art. Affy-based chemo and dosing. Panoply of genomic approaches. Epigenetics. Illumina-based platforms. Proteomics. Measurement of Pharmacodynamic endpoints. What tissues are needed + specimen collection

Notă biografică

Brian Leyland-Jones (Winship Cancer Institute, Emory University, Atlanta, Georgia) (Edited by)

Descriere

Pharmacogenetics is becoming increasingly relevant in the diagnosis, treatment, and recovery of cancer patients. A major problem facing oncologists is the outstanding varied efficacy of treatment. Promising advances in pharmacogenetics have allowed the development of effective agents which will enable personalized cancer chemotherapy to become routine for the clinical practice.